TriMas (NASDAQ:TRS) Issues FY 2025 Earnings Guidance

TriMas (NASDAQ:TRS - Get Free Report) issued an update on its FY 2025 earnings guidance on Tuesday morning. The company provided EPS guidance of 1.700-1.850 for the period, compared to the consensus EPS estimate of 1.770. The company issued revenue guidance of $962.0 million-$980.5 million, compared to the consensus revenue estimate of $973.9 million.

Analyst Ratings Changes

Separately, BWS Financial restated a "buy" rating and set a $40.00 price objective on shares of TriMas in a research note on Wednesday.

TriMas Stock Performance

TRS traded up $0.55 during midday trading on Friday, hitting $24.75. 407,166 shares of the company were exchanged, compared to its average volume of 319,868. The firm has a market capitalization of $1.01 billion, a price-to-earnings ratio of 38.67 and a beta of 0.58. The company's 50 day simple moving average is $22.47 and its 200 day simple moving average is $24.28. The company has a current ratio of 2.83, a quick ratio of 1.44 and a debt-to-equity ratio of 0.60. TriMas has a 1-year low of $19.33 and a 1-year high of $28.51.

TriMas (NASDAQ:TRS - Get Free Report) last announced its quarterly earnings results on Tuesday, April 29th. The industrial products company reported $0.46 earnings per share for the quarter, beating the consensus estimate of $0.43 by $0.03. TriMas had a return on equity of 9.21% and a net margin of 2.93%. The company had revenue of $241.67 million during the quarter, compared to analysts' expectations of $235.41 million. During the same period last year, the business earned $0.37 earnings per share. TriMas's quarterly revenue was up 6.4% on a year-over-year basis. As a group, sell-side analysts predict that TriMas will post 1.69 earnings per share for the current year.

TriMas Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Tuesday, May 13th. Investors of record on Tuesday, May 6th will be issued a dividend of $0.04 per share. This represents a $0.16 dividend on an annualized basis and a yield of 0.65%. The ex-dividend date of this dividend is Tuesday, May 6th. TriMas's dividend payout ratio (DPR) is presently 20.78%.

Insider Buying and Selling at TriMas

In related news, Director Shawn Sedaghat acquired 249,597 shares of TriMas stock in a transaction on Friday, March 7th. The stock was bought at an average cost of $23.83 per share, for a total transaction of $5,947,896.51. Following the completion of the transaction, the director now owns 346,825 shares of the company's stock, valued at approximately $8,264,839.75. The trade was a 256.71 % increase in their position. The acquisition was disclosed in a legal filing with the SEC, which is available through this link. Also, Director Jeffrey A. Fielkow acquired 2,500 shares of the firm's stock in a transaction on Friday, February 28th. The shares were bought at an average cost of $20.78 per share, for a total transaction of $51,950.00. Following the completion of the acquisition, the director now owns 11,013 shares of the company's stock, valued at approximately $228,850.14. This represents a 29.37 % increase in their ownership of the stock. The disclosure for this purchase can be found here. Over the last quarter, insiders bought 929,634 shares of company stock valued at $22,278,549. Corporate insiders own 14.20% of the company's stock.

About TriMas

TriMas Corporation engages in the design, development, manufacture, and sale of products for consumer products, aerospace, and industrial markets worldwide. The company operates through Packaging, Aerospace, and Specialty Products segments. The Packaging segment offers dispensing products, such as foaming and sanitizer pumps, lotion and hand soap pumps, beverage dispensers, perfume sprayers, and nasal and trigger sprayers; polymeric and steel caps and closures comprising food lids, flip-top and beverage closures, child resistance caps, drum and pail closures, and flexible spouts; polymeric jar products; integrated dispensers; bag-in-box products; and consumable vascular delivery and diagnostic test components under the Rieke, Taplast, Affaba & Ferrari, Intertech, Omega, and Rapak brands.